- Analysis of Urinary Cell-free DNA for Early Detection and Surveillance of Bladder CancerDudley, J.; Schroers-Martin, J.; Lazzareschi, D.; Shi, W.; Chen, S.; Liao, J.; Alizadeh, A.; Diehn, M.The Journal of molecular diagnostics: JMD , 2018, 20(6): 968.
- DNA methylation assay UriFind? enables non-invasive and convenient detection of upper tract urothelial carcinoma in a large multicentric cohortXu, C.; Li, X.; Ji, Z.; Wu, Y.; Ma, L.; Wang, S.; Lv, Q.; Tao, X.; Tan, W.; Wang, H.; Ruan, W.; Li, X.; Zhong, J.; Bibikova, M.; Chen, Z.; Fan, J-B.; Zhou, L.; Lin, T.; Huang, J.
- UriFind Assay Facilitates the Management of Urothelial Carcinoma in a Large-Scale Multicenter Prospective CohortBibikova, M.; Wang, H.; Chen, X.; Liu, Z.; Zhou, L.; Fan, J.; Lv, Q.; Wei, Q.; Chen, H.; Xu, T.; Li, L.; Wang, S.; Tan, W.; Xu, A.; Yang, J.; Zhong, J.; Ruan, W.; Chen, Z.; Fan, J.; Huang, J.; Lin, T.Annual Meeting of the Association-for-Molecular-Pathology (AMP), Salt Lake City, UT, 2023-11-14 To 2023-11-18.
期刊论文
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer
45被引28阅读
